ID   ELOA1_RAT               Reviewed;         773 AA.
AC   Q63187;
DT   11-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 148.
DE   RecName: Full=Elongin-A;
DE            Short=EloA;
DE   AltName: Full=Elongin 110 kDa subunit;
DE   AltName: Full=RNA polymerase II transcription factor SIII subunit A1;
DE   AltName: Full=SIII p110;
DE   AltName: Full=Transcription elongation factor B polypeptide 3;
GN   Name=Eloa; Synonyms=Tceb3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7660129; DOI=10.1126/science.7660129;
RA   Aso T., Lane W.S., Conaway J.W., Conaway R.C.;
RT   "Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase
RT   II.";
RL   Science 269:1439-1443(1995).
RN   [2]
RP   FUNCTION, AND SUBUNIT.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8244996; DOI=10.1016/s0021-9258(19)74431-7;
RA   Bradsher J.N., Jackson K.W., Conaway R.C., Conaway J.W.;
RT   "RNA polymerase II transcription factor SIII. I. Identification,
RT   purification, and properties.";
RL   J. Biol. Chem. 268:25587-25593(1993).
RN   [3]
RP   FUNCTION, ACTIVATION DOMAIN, INTERACTION WITH ELONGIN BC COMPLEX, AND
RP   MUTAGENESIS OF THR-549; LEU-550 AND CYS-554.
RX   PubMed=8896449; DOI=10.1002/j.1460-2075.1996.tb00940.x;
RA   Aso T., Haque D., Barstead R.J., Conaway R.C., Conaway J.W.;
RT   "The inducible elongin A elongation activation domain: structure, function
RT   and interaction with the elongin BC complex.";
RL   EMBO J. 15:5557-5566(1996).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   INTERACTION WITH ERCC6 AND CUL5.
RX   PubMed=28292928; DOI=10.1074/jbc.c117.777946;
RA   Weems J.C., Slaughter B.D., Unruh J.R., Boeing S., Hall S.M., McLaird M.B.,
RA   Yasukawa T., Aso T., Svejstrup J.Q., Conaway J.W., Conaway R.C.;
RT   "Cockayne syndrome B protein regulates recruitment of the Elongin A
RT   ubiquitin ligase to sites of DNA damage.";
RL   J. Biol. Chem. 292:6431-6437(2017).
CC   -!- FUNCTION: SIII, also known as elongin, is a general transcription
CC       elongation factor that increases the RNA polymerase II transcription
CC       elongation past template-encoded arresting sites. Subunit A is
CC       transcriptionally active and its transcription activity is strongly
CC       enhanced by binding to the dimeric complex of the SIII regulatory
CC       subunits B and C (elongin BC complex). {ECO:0000269|PubMed:8244996,
CC       ECO:0000269|PubMed:8896449}.
CC   -!- FUNCTION: As part of a multisubunit complex composed of elongin BC
CC       complex (ELOB and ELOC), elongin A/ELOA, RBX1 and CUL5;
CC       polyubiquitinates monoubiquitinated POLR2A.
CC       {ECO:0000250|UniProtKB:Q14241}.
CC   -!- SUBUNIT: Heterotrimer of an A (ELOA, ELOA2 or ELOA3P), ELOB and ELOC
CC       subunit (PubMed:8244996, PubMed:8896449). Part of a multisubunit
CC       ubiquitin ligase complex consisting of elongin BC complex (ELOB and
CC       ELOC), elongin A/ELOA, RBX1 and CUL5 (By similarity). Interacts with
CC       ERCC6; the interaction is induced by DNA damaging agents or inhibitors
CC       of RNA polymerase II elongation (PubMed:28292928). Interacts (via BC-
CC       box) with CUL5 (PubMed:28292928). {ECO:0000250|UniProtKB:Q14241,
CC       ECO:0000269|PubMed:28292928, ECO:0000269|PubMed:8244996}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14241}.
CC       Note=Localizes to sites of DNA damage. {ECO:0000250|UniProtKB:Q14241}.
CC   -!- DOMAIN: The BC-box, which mediates binding to the elongin BC complex,
CC       has the consensus sequence [APST]-L-x(3)-C-x(3)-[AILV].
CC       {ECO:0000269|PubMed:8896449}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L46816; AAA82095.1; -; mRNA.
DR   PIR; A57244; A57244.
DR   AlphaFoldDB; Q63187; -.
DR   SMR; Q63187; -.
DR   CORUM; Q63187; -.
DR   IntAct; Q63187; 5.
DR   MINT; Q63187; -.
DR   STRING; 10116.ENSRNOP00000059109; -.
DR   iPTMnet; Q63187; -.
DR   PhosphoSitePlus; Q63187; -.
DR   PaxDb; 10116-ENSRNOP00000059109; -.
DR   UCSC; RGD:3827; rat.
DR   AGR; RGD:3827; -.
DR   RGD; 3827; Eloa.
DR   eggNOG; KOG2821; Eukaryota.
DR   InParanoid; Q63187; -.
DR   PhylomeDB; Q63187; -.
DR   Reactome; R-RNO-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-RNO-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-RNO-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-RNO-75955; RNA Polymerase II Transcription Elongation.
DR   PRO; PR:Q63187; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070449; C:elongin complex; ISO:RGD.
DR   GO; GO:0090734; C:site of DNA damage; IDA:UniProtKB.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0006368; P:transcription elongation by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006367; P:transcription initiation at RNA polymerase II promoter; ISO:RGD.
DR   CDD; cd00183; TFIIS_I; 1.
DR   Gene3D; 6.10.250.3180; -; 1.
DR   Gene3D; 1.20.930.10; Conserved domain common to transcription factors TFIIS, elongin A, CRSP70; 1.
DR   InterPro; IPR051870; Elongin-A_domain.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR010684; RNA_pol_II_trans_fac_SIII_A.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   PANTHER; PTHR15141:SF75; ELONGIN-A; 1.
DR   PANTHER; PTHR15141; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 3; 1.
DR   Pfam; PF06881; Elongin_A; 1.
DR   Pfam; PF08711; Med26; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SUPFAM; SSF47676; Conserved domain common to transcription factors TFIIS, elongin A, CRSP70; 1.
DR   PROSITE; PS50181; FBOX; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..773
FT                   /note="Elongin-A"
FT                   /id="PRO_0000086962"
FT   DOMAIN          4..79
FT                   /note="TFIIS N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00649"
FT   DOMAIN          565..609
FT                   /note="F-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00080"
FT   REGION          79..480
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          521..680
FT                   /note="Activation domain"
FT                   /evidence="ECO:0000269|PubMed:8896449"
FT   REGION          549..558
FT                   /note="BC-box"
FT                   /evidence="ECO:0000269|PubMed:8896449"
FT   REGION          671..747
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        79..106
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        108..125
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..163
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..194
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        245..307
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        318..342
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..389
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        703..726
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CB77"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14241"
FT   MOD_RES         383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14241"
FT   MOD_RES         430
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CB77"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14241"
FT   MUTAGEN         549
FT                   /note="T->I: Reduces transcription activity."
FT                   /evidence="ECO:0000269|PubMed:8896449"
FT   MUTAGEN         550
FT                   /note="L->S: Reduces transcription activity and abolishes
FT                   heterotrimeric formation."
FT                   /evidence="ECO:0000269|PubMed:8896449"
FT   MUTAGEN         554
FT                   /note="C->F: Reduces transcription activity."
FT                   /evidence="ECO:0000269|PubMed:8896449"
SQ   SEQUENCE   773 AA;  87203 MW;  AEEE76E6953165AD CRC64;
     MAAESALQVV EKLQARLAAN PDPKKLLKYL KKLSVLPITV DILVETGVGK TVNSFRKHEQ
     VGNFARDLVA QWKKLVPVER NNEAEDQDFE KSNSRKRPRD VPQQEEEAEG NYQESWQASG
     SQPYSPEHRQ KKHRKLPELE RPHKVAHGHE RRDERKRCHK VSPPYSSDPE SSDYGHVQSP
     PPSSPHQMYT DLSRSPEMDQ EPIVSHPKPG KVHSNTFQDR LGVSHLGEHQ GKGAVSQNKP
     HKSSHKEKRP VDARGDEKSS VMGREKSHKA SSKEESRRLL SEDSAKEKLP SSVVKKEKDR
     EGNSLKKKLS PALDVASDNH FKKPKHKDSE KIKSDKNKQS VDSVDSGRGT GDPLPRAKDK
     VPNNLKAQEG KVRTNSDRKS PGSLPKVEEM DMDDEFEQPT MSFESYLSYD QPRKKKKKVV
     KTSGTALGEK GLKKKDSKST SKNLNSAQKL PKANENKSDK LQPAGAEPTR PRKVPTDVLP
     ALPDIPLPAI QTNYRPLPSL ELISSFQPKR KAFSSPQEEE EAGFTGRRMN SKMQVYSGSK
     CAYLPKMMTL HQQCIRVLKN NIDSIFEVGG VPYSVLEPVL ERCTPDQLYR IEECNHVLIE
     ETDQLWKVHC HRDFKEERPE EYESWREMYL RLQDAREQRL RLLTNNIRSA HANKPKGRQA
     KMAFVNSVAK PPRDVRRRQE KFGTGGAAVP EKVRIKPAPY TTGSSHVPAS NSSSSFHSSP
     EELAYEGPST SSAHLAPVAS SSVSYDPRKP AVKKIAPMMA KTIKAFKNRF SRR
//
